Interleukin-6 Inhibitors Improve Overall Survival Outcomes in Severe COVID-19
Treatment with interleukin-6 (IL-6) inhibitors decreased the risk of death among patients with COVID-19 infection by 75% compared with standard…
Treatment with interleukin-6 (IL-6) inhibitors decreased the risk of death among patients with COVID-19 infection by 75% compared with standard…
The risk of immediate allergic reactions or anaphylaxis after a second dose of the SARS-CoV-2 mRNA vaccine is low in…
The Food and Drug Administration (FDA) has scheduled a virtual meeting of its Vaccines and Related Biological Products Advisory Committee…
COVID-19 encourages nightmare activity, according to new research from Nature and Science of Sleep. Patients with COVID-19 have experienced increased…
The United States is in the midst of 2 epidemics, COVID-19 and obesity. “Teaching real nutrition is the strongest way…
Prosociality and willingness to undergo COVID-19 vaccination are associated, researchers in Poland observed in a random-intercept cross-lagged panel model (RI-CLPM).…
Heterologous COVID-19 vaccination with the ChAdOx1 nCoV-19 and BNT162b2 vaccines increases in vitro neutralizing activity and may confer cross-protection against…
This article is the first of a multi-part series on burnout among pulmonary and critical care physicians. Ongoing demands related…
A patient’s gut microbiome may be linked to the risk of developing long-haul COVID-19 after initial infection with SARS-CoV-2, according…
Individuals who have asymptomatic COVID-19 may develop post-COVID conditions. These conditions can present as different types and combinations of health…